Carisma Therapeutics's total assets for Q2 2025 were $5.01M, a decrease of -68.58% from the previous quarter. CARM total liabilities were $51.02M for the fiscal quarter, a -3.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.